About T1D Fund
Investments are directed by the T1D Fund toward companies advancing Type 1 Diabetes (T1D) products within the biotechnology sector. Operations are centered in Boston, United States, with a focus on venture philanthropy to support innovative treatments. The portfolio encompasses firms like Bigfoot Biomedical, Diasome Pharmaceuticals, and eGenesis Bio, where financial and strategic backing is provided to accelerate T1D solutions.
- Headquarter Boston, United States
-
Sectors
Financial Services
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of T1D Fund
Unlock access to complete
Unlock access to complete
Funding Insights of T1D Fund
Detailed funding history for T1D Fund
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by T1D Fund
Investment portfolio details for T1D Fund
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - T1D Fund
Detailed financials for T1D Fund
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
T1d Fund Comparisons
Peer comparison for T1D Fund
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of T1D Fund
Detailed competitors of T1D Fund
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on T1d Fund
Complete news archive for T1D Fund
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about T1D Fund
T1D Fund is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Investments are directed by the T1D Fund toward companies advancing Type 1 Diabetes (T1D) products within the biotechnology sector. Operations are centered in Boston, United States, with a focus on venture philanthropy to support innovative treatments. The portfolio encompasses firms like Bigfoot Biomedical, Diasome Pharmaceuticals, and eGenesis Bio, where financial and strategic backing is provided to accelerate T1D solutions.